|
1
|
de Miguel-Luken MJ, Chaves-Conde M, de
Miguel-Luken V, Muñoz-Galván S, López-Guerra JL, Mateos JC, Pachón
J, Chinchón D, Suarez V and Carnero A: MAP17 (PDZKIP1) as a novel
prognostic biomarker for laryngeal cancer. Oncotarget.
6:12625–12636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Butler A, Rigby MH, Scott J, Trites J,
Hart R and Taylor SM: A retrospective review in the management of
T3 laryngeal squamous cell carcinoma: An expanding indication for
transoral laser microsurgery. J Otolaryngol Head Neck Surg.
45:342016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Q, Liu Y, Hu G, Wang R, Zhao Y and
Zhang M: The survival rate and larynx preservation in elderly
cancer patients who received surgical operation: A retrospective
cohort study. Int J Surg. 36:342–346. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Henriques de Figueiredo B and Grégoire V:
How to minimize morbidity in radiotherapy of pharyngolaryngeal
tumors? Curr Opin Otolaryngol Head Neck Surg. 24:163–169. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cui N, Hao G, Zhao Z, Wang F, Cao J and
Yang A: MicroRNA-224 regulates self-renewal of mouse spermatogonial
stem cells via targeting DMRT1. J Cell Mol Med. 20:1503–1512. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meza-Sosa KF, Valle-Garcia D, Pedraza-Alva
G and Perez-Martinez L: Role of microRNAs in central nervous system
development and pathology. J Neurosci Res. 90:1–12. 2012.
View Article : Google Scholar
|
|
7
|
Leng R, Zha L and Tang L: miR-718
represses VEGF and inhibits ovarian cancer cell progression. FEBS
Lett. 588:2078–2086. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol. 15:4292014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang SS, Jiang WW, Smith I, Poeta LM,
Begum S, Glazer C, Shan S, Westra W, Sidransky D and Califano JA:
MicroRNA alterations in head and neck squamous cell carcinoma. Int
J Cancer. 123:2791–2797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin C, Zhang Y and Li J: Upregulation of
miR-196a promotes cell proliferation by downregulating
p27kip1 in laryngeal cancer. Biol Res. 49:402016.
View Article : Google Scholar
|
|
11
|
Krishnan AR, Zheng H, Kwok JG, Qu Y, Zou
AE, Korrapati A, Li PX, Califano JA, Hovell MF, Wang-Rodriguez J
and Ongkeko WM: A comprehensive study of smoking-specific microRNA
alterations in head and neck squamous cell carcinoma. Oral Oncol.
72:56–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhan YH, Liu J, Qu XJ, Hou KZ, Wang KF,
Liu YP and Wu B: β-Elemene induces apoptosis in human renal-cell
carcinoma 7860 cells through inhibition of MAPK/ERK and
PI3K/Akt/mTOR signalling pathways. Asian Pac J Cancer Prev.
13:2739–2744. 2012. View Article : Google Scholar
|
|
13
|
Du HF, Ou LP, Song XD, Fan YR, Yang X, Tan
B, Quan Z, Luo CL and Wu XH: Nuclear factor-κB signaling pathway is
involved in phospholipase Cε-regulated proliferation in human renal
cell carcinoma cells. Mol Cell Biochem. 389:265–275. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hannes S, Abhari BA and Fulda S: Smac
mimetic triggers necroptosis in pancreatic carcinoma cells when
caspase activation is blocked. Cancer Lett. 380:31–38. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nie F, Liu T, Zhong L, Yang X, Liu Y, Xia
H, Liu X, Wang X, Liu Z, Zhou L, et al: MicroRNA-148b enhances
proliferation and apoptosis in human renal cancer cells via
directly targeting MAP3K9. Mol Med Rep. 13:83–90. 2016. View Article : Google Scholar :
|
|
16
|
Xia J, Cao T, Ma C, Shi Y, Sun Y, Wang ZP
and Ma J: miR-7 suppresses tumor progression by directly targeting
MAP3K9 in pancreatic cancer. Mol Ther Nucleic Acids. 13:121–132.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu B, Xu T, Liu H, Min Q, Wang S and Song
Q: miR-490-5p suppresses cell proliferation and invasion by
targeting BUB1 in hepatocellular carcinoma cells. Pharmacology.
100:269–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using rea time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Fang ZQ, Li MC, Zhang YQ and Liu XG:
miR-490-5p inhibits the metastasis of hepatocellular carcinoma by
down-regulating E2F2 and ECT2. J Cell Biochem. 119:8317–8324. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu W, Feng L, Li P, Wang Y, Du Y, Chen X,
Wu S, Zhao G and Lou W: Effects of HPV-16 infection on
hypopharyngeal squamous cell carcinoma and FaDu cells. Oncol Rep.
35:99–106. 2016. View Article : Google Scholar
|
|
21
|
Li H, Wawrose JS, Gooding WE, Garraway LA,
Lui VW, Peyser ND and Grandis JR: Genomic analysis of head and neck
squamous cell carcinoma cell lines and human tumors: A rational
approach to preclinical model selection. Mol Cancer Res.
12:571–582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lan G, Yang L, Xie X, Peng L and Wang Y:
MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in
human bladder cancer. Arch Med Sci. 11:561–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Durkin JT, Holskin BP, Kopec KK, Reed MS,
Spais CM, Steffy BM, Gessner G, Angeles TS, Pohl J, Ator MA and
Meyer SL: Phosphoregulation of mixed-lineage kinase 1 activity by
multiple phosphorylation in the activation loop. Biochemistry.
43:16348–16355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slattery ML, Hines LH, Lundgreen A,
Baumgartner KB, Wolff RK, Stern MC and John EM: Diet and lifestyle
factors interact with MAPK genes to influence survival: The Breast
Cancer Health Disparities Study. Cancer Causes Control.
25:1211–1225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Ye L, Wen D and Chen F: miR-490-5p
inhibits hepatocellular carcinoma cell proliferation, migration and
invasion by directly regulating ROBO1. Pathol Oncol Res. 25:1–9.
2019. View Article : Google Scholar
|
|
27
|
Yang Z, Li K, Liang Q, Zheng G, Zhang S,
Lao X, Liang Y and Liao G: Elevated hydrostatic pressure promotes
ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9
expression via Wnt/β-catenin signalling. J Oral Pathol Med.
47:836–846. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Tao Y and Li X: Expression of
MMP-9/TIMP-2 in nasal polyps and its functional implications. Int J
Clin Exp Pathol. 8:14556–14561. 2015.
|
|
29
|
Chang X, Xu X, Xue X, Ma J, Li Z, Deng P,
Chen J, Zhang S, Zhi Y and Dai D: NDRG1 controls gastric cancer
migration and invasion through regulating MMP-9. Pathol Oncol Res.
22:789–796. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang L, Song X, Zhu J, Li M, Ji Y, Wu F,
Chen Y, Cui X, Hu J, Wang L, et al: Tumor suppressor microRNA-34a
inhibits cell migration and invasion by targeting
MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma. Int J
Oncol. 51:378–388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu LS, Huang RH, Lai HW, Hsu HT, Sung WW,
Hsieh MJ, Wu CY, Lin YM, Chen MK, Lo YS and Chen CJ: KLF6 inhibited
oral cancer migration and invasion via downregulation of
mesenchymal markers and inhibition of MMP-9 activities. Int J Med
Sci. 14:530–535. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yazdani J, Ghavimi MA, Jabbari Hagh E and
Ahmadpour F: The role of E-cadherin as a prognostic biomarker in
head and neck squamous carcinoma: A systematic review and
meta-analysis. Mol Diagn Ther. 22:523–535. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tiwari N, Gheldof A, Tatari M and
Christofori G: EMT as the ultimate survival mechanism of cancer
cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu S, Du Y, Beckford J and Alachkar H:
Upregulation of the EMT marker vimentin is associated with poor
clinical outcome in acute myeloid leukemia. J Transl Med.
16:1702018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu CY, Lin HH, Tang MJ and Wang YK:
Vimentin contributes to epithelial-mesenchymal transition cancer
cell mechanics by mediating cytoskeletal organization and focal
adhesion maturation. Oncotarget. 6:15966–15983. 2015.PubMed/NCBI
|
|
36
|
Łukaszewicz-Zając M, Mroczko B,
Guzińska-Ustymowicz K, Pryczynicz A, Gryko M, Kemona A, Kędra B and
Szmitkowski M: Matrix metalloproteinase 2 (MMP-2) and their tissue
inhibitor 2 (TIMP-2) in gastric cancer patients. Adv Med Sci.
58:235–243. 2013. View Article : Google Scholar
|
|
37
|
Urbaniak-Kujda D, Kapelko-Slowik K, Prajs
I, Dybko J, Wolowiec D, Biernat M, Slowik M and Kuliczkowski K:
Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9),
tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2),
and EMMPRIN (CD147) in multiple myeloma. Hematology. 21:26–33.
2016. View Article : Google Scholar
|
|
38
|
Chen K, Zeng J, Tang K, Xiao H, Hu J,
Huang C, Yao W, Yu G, Xiao W, Guan W, et al: miR-490-5p suppresses
tumour growth in renal cell carcinoma through targeting PIK3CA.
Biol Cell. 108:41–50. 2016. View Article : Google Scholar
|
|
39
|
Luo Q, Li W, Zhao T, Tian X, Liu Y and
Zhang X: Role of miR-148a in cutaneous squamous cell carcinoma by
repression of MAPK pathway. Arch Biochem Biophys. 583:47–54. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mao D, Qiao L, Lu H and Feng Y: B-cell
translocation gene 3 overexpression inhibits proliferation and
invasion of colorectal cancer SW480 cells via Wnt/β-catenin
signaling pathway. Neoplasma. 63:705–716. 2016. View Article : Google Scholar
|
|
41
|
Jia S, Qu T, Wang X, Feng M, Yang Y, Feng
X, Ma R, Li W, Hu Y, Feng Y, et al: KIAA1199 promotes migration and
invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression
and serves as a poor prognosis marker in gastric cancer. PLoS One.
12:e01750582017. View Article : Google Scholar
|
|
42
|
Yang D, Du G, Xu A, Xi X and Li D:
Expression of miR-149-3p inhibits proliferation, migration, and
invasion of bladder cancer by targeting S100A4. Am J Cancer Res.
7:2209–2219. 2017.PubMed/NCBI
|
